DE60221041D1 - Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren - Google Patents

Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren

Info

Publication number
DE60221041D1
DE60221041D1 DE60221041T DE60221041T DE60221041D1 DE 60221041 D1 DE60221041 D1 DE 60221041D1 DE 60221041 T DE60221041 T DE 60221041T DE 60221041 T DE60221041 T DE 60221041T DE 60221041 D1 DE60221041 D1 DE 60221041D1
Authority
DE
Germany
Prior art keywords
benzothia
zin
dia
derivatives
ampa modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60221041T
Other languages
English (en)
Other versions
DE60221041T2 (de
Inventor
Alex Cordi
Patrice Desos
Pierre Lestage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of DE60221041D1 publication Critical patent/DE60221041D1/de
Application granted granted Critical
Publication of DE60221041T2 publication Critical patent/DE60221041T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60221041T 2001-12-21 2002-12-20 Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren Expired - Fee Related DE60221041T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0116622 2001-12-21
FR0116622A FR2833950B1 (fr) 2001-12-21 2001-12-21 Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2002/004484 WO2003053947A1 (fr) 2001-12-21 2002-12-20 Derives de benzothia(dia)zine et leur utilisation comme modulateurs ampa

Publications (2)

Publication Number Publication Date
DE60221041D1 true DE60221041D1 (de) 2007-08-16
DE60221041T2 DE60221041T2 (de) 2008-04-10

Family

ID=8870810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221041T Expired - Fee Related DE60221041T2 (de) 2001-12-21 2002-12-20 Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren

Country Status (26)

Country Link
US (1) US7250411B2 (de)
EP (1) EP1456189B1 (de)
JP (1) JP2005517668A (de)
KR (1) KR100606606B1 (de)
CN (1) CN1606550A (de)
AR (1) AR038029A1 (de)
AT (1) ATE366245T1 (de)
AU (1) AU2002365017B2 (de)
BR (1) BR0215145A (de)
CA (1) CA2471057A1 (de)
DE (1) DE60221041T2 (de)
DK (1) DK1456189T3 (de)
EA (1) EA007271B1 (de)
ES (1) ES2289182T3 (de)
FR (1) FR2833950B1 (de)
GE (1) GEP20063758B (de)
HU (1) HUP0402584A2 (de)
MA (1) MA27089A1 (de)
MX (1) MXPA04005838A (de)
NO (1) NO20042684L (de)
NZ (1) NZ533330A (de)
PL (1) PL369767A1 (de)
PT (1) PT1456189E (de)
UA (1) UA78743C2 (de)
WO (1) WO2003053947A1 (de)
ZA (1) ZA200404296B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856065B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2865474B1 (fr) * 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877342B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0724625D0 (en) * 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0636124A1 (de) * 1992-04-15 1995-02-01 Aventis Pharma S.A. 3,4-dihydro-2h-1,2,4-benzothiadiazin-1,1-dioxid-3-carbosäure-derivate, ihre herstellung und diese enthaltende artzneimittel
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN1606550A (zh) 2005-04-13
ZA200404296B (en) 2005-06-01
JP2005517668A (ja) 2005-06-16
NO20042684L (no) 2004-06-25
EA007271B1 (ru) 2006-08-25
US20050014744A1 (en) 2005-01-20
EP1456189B1 (de) 2007-07-04
NZ533330A (en) 2006-05-26
AU2002365017A1 (en) 2003-07-09
PT1456189E (pt) 2007-09-20
PL369767A1 (en) 2005-05-02
WO2003053947A1 (fr) 2003-07-03
UA78743C2 (en) 2007-04-25
MXPA04005838A (es) 2004-09-10
DE60221041T2 (de) 2008-04-10
FR2833950A1 (fr) 2003-06-27
ATE366245T1 (de) 2007-07-15
AU2002365017B2 (en) 2007-12-13
EP1456189A1 (de) 2004-09-15
GEP20063758B (en) 2006-02-27
EA200400756A1 (ru) 2004-10-28
US7250411B2 (en) 2007-07-31
BR0215145A (pt) 2004-10-19
CA2471057A1 (fr) 2003-07-03
HUP0402584A2 (hu) 2005-04-28
ES2289182T3 (es) 2008-02-01
AR038029A1 (es) 2004-12-22
KR100606606B1 (ko) 2006-08-01
MA27089A1 (fr) 2004-12-20
KR20040065276A (ko) 2004-07-21
DK1456189T3 (da) 2007-11-05
FR2833950B1 (fr) 2005-12-16

Similar Documents

Publication Publication Date Title
DE60006580D1 (de) Benzazolderivate und ihre verwendung als jnk modulatoren
DE60005973D1 (de) Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
ATE522506T1 (de) 4-aminopicolinate und ihre verwendung als herbizide
ATE375987T1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
DE60106423D1 (de) Entzündungshemmende verbindungen und ihre verwendung
DE60123210D1 (de) Picolinsäure-derivate und ihre verwendung als fungizide
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
DE50110620D1 (de) Benzoylpyrazole und ihre verwendung als herbizide
DE60234167D1 (de) Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren
ATE321023T1 (de) 3-phenoxy-1-phenyl acetylenderivate und ihre verwendung als herbizide
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
DE60321958D1 (de) Indazolderivate und ihre verwendung als crf antagonisten
ATE362469T1 (de) 2,7-disubstituierteindole und ihre verwendung als 5-ht6 modulatoren
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
DE50209680D1 (de) Pyrazolylsubstituierte heterocyclen und ihre verwendung als schädlingsbekämpfungsmittel
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE60322052D1 (de) N-acylaminoacetonitril-derivate und ihre verwendung zur kontrolle von parasiten
DE60221041D1 (de) Benzothia(dia)zinderivate und ihre verwendung als ampa-modulatoren
DE60116732D1 (de) Isothiazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel
ATE368654T1 (de) Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen- inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee